categorii
- Allergy / Immunology
- Anaesthesiology
- Anatomy
- Behavioural Medicine
- Biochemistry
- Cardiology
- Clinical Medicine
- Critical Care
- Dentistry
- Dermatology
- Embryology
- Emergency Medicine
- Endocrinology
- Epidemiology
- Evidence-Based Medicine
- Gastroenterology
- Genetics
- Geriatrics
- Haematology
- Health Professions
- Histology
- Infectious & Contagious Diseases
- Medicine: general issues
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Obstetrics / Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Otorhinolaryngology (ENT)
- Paediatrics
- Pathology
- Pharmacology
- Physiology
- Plastic Surgery
- Primary Care / General Practice
- Psychiatry
- Pulmonary & Respiratory Medicine
- Radiology / Imaging
- Rehabilitation Medicine
- Rheumatology
- Sleep Medicine
- Surgery
- Urology
- Veterinary Medicine
Home » Haematology » Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America
Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America
|
|
||||||||
- Seria:
- Categoria:
- Haematology
- Editia:
- Anul publicarii:
- 14.09.2010
- ISBN:
- 9781437725292
- Editura:
- Saunders
- Tip coperta:
- Hardback
- Format:
- Nr. pagini:
- 0
- Nr. ilustratii:
- Audienta:
Descriere:
This issue addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. New anticoagulants discussed include oral Xa inhibitors, oral IIa inhibitors, agents for the treatment of HIT, and use of low molecular weight heparin to improve survival in cancer patients.
This issue addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. New anticoagulants discussed include oral Xa inhibitors, oral IIa inhibitors, agents for the treatment of HIT, and use of low molecular weight heparin to improve survival in cancer patients.
Recomandata pentru:
06
06